Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0J6NI
|
|||
Former ID |
DNC011028
|
|||
Drug Name |
4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine
|
|||
Synonyms |
CHEMBL1171443; 4-((1H-Imidazol-4-yl)methyl)-1-phenylpiperidine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C15H19N3
|
|||
Canonical SMILES |
C1CN(CCC1CC2=CN=CN2)C3=CC=CC=C3
|
|||
InChI |
1S/C15H19N3/c1-2-4-15(5-3-1)18-8-6-13(7-9-18)10-14-11-16-12-17-14/h1-5,11-13H,6-10H2,(H,16,17)
|
|||
InChIKey |
DKJLGZJEDGFKIC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Histamine H3 receptor (H3R) | Target Info | Inhibitor | [1] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Reactome | Histamine receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | Monoamine Transport | |||
GPCRs, Class A Rhodopsin-like | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Synthesis and structure-activity relationships of N-aryl-piperidine derivatives as potent (partial) agonists for human histamine H3 receptor. Bioorg Med Chem. 2010 Jul 15;18(14):5441-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.